Prothena Corporation PLC
Change company Symbol lookup
Select an option...
PRTA Prothena Corporation PLC
SNC State National Companies Inc
T AT&T Inc
KMX Carmax Inc
BAC Bank of America Corp
STDAY Stada Arzneimittel AG
PSBP Provident State Bank Inc
AJG Arthur J Gallagher & Co
ALL Allstate Corp
PFK Prudential Financial Inc
Go

Health Care : Biotechnology | Small Cap Growth
Based in IrelandCompany profile

Prothena Corporation Public Limited Company is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). The Company has generated monoclonal antibodies that selectively bind to amyloidogenic (diseased) forms of the Transthyretin (TTR)-mediated amyloidosis (ATTR) protein. The Company's pipeline also includes late discovery-stage programs for which the Company is testing the efficacy of antibodies in preclinical models of diseases related to amyloid or cell adhesion.

Closing Price
$54.13
Day's Change
0.12 (0.22%)
Bid
--
Ask
--
B/A Size
--
Day's High
54.61
Day's Low
52.82
Volume
(Heavy Day)
Volume:
589,133
10-day average volume:
263,188
589,133
  • Prev Close
    54.01
  • Today's Open
    54.00
  • Day's Range
    52.82-54.61
  • Avg Vol (10-day)
    263.2K
  • Last (time)
    3:59p ET 04/28/17
  • Last (size)
    17
  • 52-Wk Range
    33.53 - 68.18
    LowHigh
  • (06/27/16 - 11/16/16)
    20.61%
  • 60.5%
  • Market Cap
    1.9B
  • Shares Outstanding
    35.0M
  • -4.66
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.6
  • 105.01
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2017 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , , and

Copyright © 2017. All rights reserved.